ABSTRACT OBJECTIVE: To explore the effects and mechanisms of siRNA targeting survivin of inducing apoptosis in rat HSC-T6 cells. METHODS: The experiment was divided into blank group, pGPU6/GFP/Neo-shNC group and pGPU6/GFP/ Neo-siRNA group. The siRNA was transfected into HSC-T6 cells mediated by Lipofectamine TM2000 for 24 h, and then the effi ciency of transfection was observed by fl uorescence microscopy. After transfection for 48h, the expression of survivin mRNA and protein was assessed by reverse transcription-polyme-rase chain reaction (RT-PCR) method and Western-blot, and the form of cells was observed by microscopy. The apoptosis rate of HSC-T6 cells was measured by the fl ow cytometry with PI staining. The expression of caspase-3 protein was assessed by western-blot. RESULTS: The prominent apoptosis of the pGPU6/GFP/Neo-siRNA group by PI staining was high, there was signifi cant difference comparing with blank group and pGPU6/GFP/Neo-shNC group (p < 0.05). The prominent apoptosis of blank group and pGPU6/GFP/Neo-shNC group was weak, there was no signifi cant difference among blank group and pGPU6/GFP/Neo-shNC group (p > 0.05). The expression of caspase-3 by Westernblot in pGPU6/GFP/Neo-siRNA group was high, there was signifi cant difference comparing with blank group and pGPU6/GFP/Neo-shNC group (p < 0.05), the expression of caspase-3 in blank group and pGPU6/GFP/ Neo-shNC group was weak, there was no signifi cant difference among blank group and pGPU6/GFP/NeoshNC group (p > 0.05). CONCLUSION: siRNA targeting survivin can inhibit the expression of survivin mRNA and protein in rat HSC-T6 cells. Expression of survivin is negative correlation with expression of caspase-3. siRNA targeting survivin may upregulate expression of caspase-3 and increase apoptosis of rat Ref. 24). Text in PDF www.elis.sk.
Introduction
Hepatic fi brosis (HF) is an inevitable stage of the progression of various chronic hepatic diseases. It is the key to the cure of chronic hepatic diseases and to reversing pathological changes at HF stage (1) . The pathway of the genesis of HF is the activation of the hepatic stellate cell (HSC), which is crucially linked to the formation of HF (2) . Among various treatment methods of HF, the HSC comes into focus of research as a major target (2) (3) (4) (5) . However, there has been found no completely specifi c gene or receptor molecule on HSC. So far, no major breakthrough has been made in the treatment of HF.
Survivin is a new inhibitor of apoptotic protein (IAP), obtained by Altieri et al in 1997 through isolating hybrid between cDNA of effector cell protease receptor 1 (EPR-1) and that in the human genomic library (6) . It is the strongest inhibitor of apoptosis protein that has been ever found so far. As opposed to other IAP family members, the survivin gene expression has clear tissue selectivity. It generally has high expression in embryonic tissues and malignant tumors, whereas it is not expressed in differentiated and mature tissues (except for trace amount of expression in placenta, endometrium in proliferation period and secretion period) and in paracancerous normal tissues (7) . As a new member, IAP is considered an ideal target for genetic treatment of tumors due to its tissue selectivity and unique biological functions (8, 9) .
De et al (10) found that static HSC had no survivin gene expression. In animal model for activated HSC in culture, bile duct ligation or nitrogen tetrachloride treatment, the survivin gene expression had a signifi cant increase. Minicis DS et al found that survivin had high expression in activated HSC (11) . Therefore, survivin might be correlated with the genesis and development of hepatic fi brosis.
Caspase-3 belongs to the interleikin-1 converting enzyme (ICE) family as its most important member. It is an apoptotic proteinase. In normal conditions, the caspase-3 in the cytoplasm exists in its original form as an inactive enzyme. Once activated, the cells undergo apoptosis (12) . Research indicates that caspase-3 induces cell apoptosis via mechanism as follows: (1) inhibition or inactivation of protein during the DNA formation; (2) inhibition of inhibitor of apoptosis protein; (3) cutting of structural proteins of the cell (13) . During their research on induction of cell apoptosis, Fas, Cui JH et al indicated the activation of caspase-3 and that the serine proteinase inhibitor could inhibit the activation of caspase-3 and cell apoptosis simultaneously (14) . In addition, studies also found that after activation, caspase-3 could cause cell apoptosis with the amplifi cation effect of proteinase cascade. Therefore, caspase-3 is called cell-death proteinase (15) . Therefore a question is to be raised, namely whether the activated HSC expresses the survivin gene and inhibits the expression of caspase-3, while the process fi nally results in the inhibition of HSC apoptosis.
RNA interference technology is a specifi c gene inactivation technology, which introduces double-strand RNA into the cell and under the effect of Dicer enzyme it produces active molecules to interfere with RNA fragments. In this way, it causes specifi c degradation of mRNA homogeneous to RNA fragment and inhibits the expression of the corresponding genes, so as to produce the effect similar to gene knockdown (16) . With the strong effect, stability and persistence as well as the transmission of the effects to the fi lial generation, the RNA interference technology is widely applied in the studies of genetic functions and treatment of tumors (17) (18) . This research uses RNA interference technology to produce the targeted effects on survivin gene, so as to study the infl uence on HSC apoptosis and caspase-3 gene. The work provides a theoretical foundation for the treatment of hepatic fi brosis.
Methods and materials
HSC-T6 cells were brought from South China University. HCS-T6 cells were incubated in culture medium with 5 % CO 2 in an incubator (SANYO company, Japan), according to the manufacturer instructions for indicated period of time after replacement of transfection culture medium in DMEM with 5 % FBS. Then, HCS-T6 cells were collected by Centrifuge (Eppendorf Company, Germany). HCS-T6 cells were divided into blank group (not transfected), pGPU6/GFP/Neo-shNC group (transfecting pGPU6/GFP/ Neo-shNC, Zimmer Biological Company, Shanghai, China) and pGPU6/GFP/Neo-siRNA group (transfecting pGPU6/GFP/NeosiRNA, Zimmer Biological Company, Shanghai, China). The siR-NA was transfected into cells mediated by LipofectamineTM2000 for 24 h, according to the manufacturer instructions, and then the effi ciency of transfection was observed by fl uorescence microscopy (Olympus Company, Japan). After 48 h following transfection, the expression of survivin mRNA was assessed by reverse transcription-polymerase chain reaction (RT-PCR) method. Total RNA was extracted by Trizol reagent (Invitrogen). Reaction mixture (20 μl) contained RNA (2 μl), oligo(dT) 18 (1 μl), Reaction Buffer (4 μl), RiblockTM RNase inhibition (1 μl), 10 Mm dNTP Mix (2 μl), RevertAidTM M-Mulv Reverse Transcriptase 200 μ/ μl (1 μl), DEPC-treated water (9 μl). The PCR conditions were as follows: activation of enzyme at 94 °C for 4 min, 35 circles of denaturation at 94 °C for 30 s, annealing at 57 °C for 30 s, and extension at 72 °C for 30 s. Relative expression of survivin mRNA was calculated as ratios normalized against those of β-action. The expression of survivin protein and caspase-3 protein was assessed by Western-blot. Cells were harvested and lysed in 1.0 ml of lysis buffer. Lysates were clarifi ed by centrifugation at 12000 r/min for 10 min. Protein was processed for SDS-PAGE, which was performed on 12 % gels. The blots were blocked with 5% non-fat milk in Tris-buffered saline for 2 h and then incubated with antibodies in 5 % non-fat milk in TBS, then washed with TBS and incubated with secondary antibodies conjugated with horseradish peroxidase in 5 % non-fat milk in TBS. After washing with TBS, the bound antibodies were visualized by enhanced chemiluminescence and recorded on X-ray fi lms. The form of HSC-T6 cells was observed by microscopy (Olympus Company Japan). The apoptosis rate of HSC-T6 cells was measured by fl ow cytometry with PI staining (FACScan Becton Dickinson, USA ).
Statistical analysis
Data were expressed as mean ± SD. Differences with p < 0.05 were considered statistically signifi cant. These analyses were performed using SPSS16.0 software.
Results

Observation of siRNA transfecting into HSC-T6 cells
After 24 h following transfection, clear and green fl uorescence was observed by inversion fl uorescence microscope in HSC-T6, and the effi ciency of transfection was attained to 75 % (Fig. 1) .
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Expression of survivin mRNA in siRNA transfection of HSC-T6
The expression of survivin mRNA in HSC-T6 The expression of survivin mRNA in blank group and pGPU6/ GFP/Neo-shNC group by RT-PCR was higher; there was no significant difference between blank group and pGPU6/GFP/Neo-shNC group (p > 0.05). The expression of survivin mRNA in pGPU6/ GFP/Neo-siRNA group was obviously weak; there was a significant difference when compared with blank group and pGPU6/ GFP/Neo-shNC group (p < 0.05) (Fig. 2) .
The expression of survivin protein in HSC-T6 The expression of survivin protein in blank group and pGPU6/ GFP/Neo-shNC group by Western blotting was higher; there was no signifi cant difference between blank group and pGPU6/GFP/ Neo-shNC group (p > 0.05). The expression of survivin protein group was obviously weak; there was signifi cant difference when compared with blank group and pGPU6/GFP/Neo-shNC group (p < 0.05) (Fig. 3) .
Apoptosis of siRNA transfection of HSC-T6
Transformation of HSC-T6 When observed under microscope 48 h after transfection of HSC-T6 cells, HSC-T6 cells were adhering to the wall, had normal morphology, and were in a vigorous growth stage in pGPU6/GFP/NeoshNC group. In pGPU6/GFP/Neo-siRNA group, whereas, HSC-T6 cells were suspended from the wall, they were shrunk, rounded, their number decreased, and they yielded slow growth (Fig. 4) .
Apoptosis rate of HSC-T6 cells by the fl ow cytometry When cells became apoptotic because of cellular DNA content by fl ow cytometry, there was a feature, in which the left of diploid peak (G1 peak) exhibited sub-diploid karyotype peak (Ap peak). In blank group and pGPU6/GFP/Neo-shNC group, there was no Ap peak. However, in pGPU6/GFP/Neo-siRNA, there was an obvious AP peak, which showed that the apoptosis rate of pGPU6/GFP/Neo-siRNA group was higher than those in blank group and pGPU6/GFP/Neo-shNC group at a signifi cant difference (p < 0.05) (Fig. 5) .
The expression of caspase-3 protein in HSC-T6
The expression of caspase-3 protein in blank group and pGPU6/GFP/Neo-shNC group by Western blot was weak, there was no signifi cant difference between blank group and pGPU6/ GFP/Neo-shNC group (p > 0.05). The expression of caspase-3 protein in pGPU6/GFP/Neo-siRNA group was obviously higher; there was a signifi cant difference when compared with blank group and pGPU6/GFP/Neo-shNC group (p < 0.05) (Fig. 6) .
Discussion
HF is a wound-healing response to hepatic damage caused by various reasons by the liver itself. It is manifested as hyperplasia and deposition of connective tissues in the liver, which is an inevitable stage of the progression of various chronic hepatic diseases to hepatic cirrhosis. In clinical practice, the question whether the pathological changes can be reversed at the HF stage is considered to be the key to the cure of chronic hepatic diseases (1) . The pathologic mechanisms of chronic hepatic damage differ based on the variability of causes. However, the fi nal pathway of HF genesis is the activation of HSC. The activated HSC can synthesize a large amount of collagen (except for type V collagen), hyaluronic acid, laminin, fi bronectin, etc. and participates in the synthesis and regulation of collagen and its inhibitors (2-5). The amount of collagen synthesized by hepatic stellate cells is more than ten times greater than that produced by hepatic cells and over 20 times greater than that produced by sinusoidal endothelial cells. HSC also impedes the degradation of ECM and activates further static HSC by secreting tissue inhibitor of metalloproteinase (TIMPs) (18) and transforming growth factor β (TGF-β) (19) , which forms a vicious circle diffi cult to be reversed. The explanation of HSC activation mechanism has turned HSC into an important target in the effort of curing HF (20) . The search for specifi c gene or receptor molecule of HSC is crucial for the treatment of hepatic fi brosis. Cationic liposome is a new liposome with cation-mediated transfection. It has a unique structure of strongly negative electronic head of the spermine gene, which can form spontaneously complexes with DNA with strong transfection ability. Moreover, it is safe for cells because it has no toxic effects. The study shows that 24 h following transfection of siRNA with cationic liposome, green fl uorescence in pGPU6/GFP/Neo-shNC and pGPU6/GFP/ Neo-siRNA cells can be observed under the inverted fl uorescence microscope. The transfection effi ciency can reach approx. 75 %. The research provides a solid foundation for further studies.
Minicis found that survivin had high expression in activated HSC (10) . In addition, survivin is the strongest apoptosis inhibitor that has been ever known. It enhances the abnormal proliferation of cells by interfering with mitosis (6-7). As an answer to the question whether siRNA transfection technology inhibits the survivin gene expression in activated HSC, it is found out that the survivin mRNA and protein expressions were the highest in the blank group and pGPU6/GFP/Neo-shNC group, and the survivin mRNA and protein expressions were the lowest in pGPU6/GFP/ Neo-siRNA group. The difference between the blank group and the pGPU6/GFP/Neo-shNC group showed no statistical significance (p > 0.05). The difference between the blank group, pGPU6/ GFP/Neo-shNC group and pGPU6/GFP/Neo-siRNA group was statistically signifi cant (p < 0.05). This indicates that siRNA can inhibit survivin gene expression.
In order to answer to the question whether siRNA can promote HSC apoptosis, even though it inhibits survivin gene expression, the morphology of cells after 48 h of transfection was observed under the inverted microscope and the cell apoptosis rate was measured with fl ow cytometry. The results indicate that the cell volume in pGPU6/GFP/Neo-siRNA group is decreased, the cells shrink, and the apoptosis increases. When compared with the blank group and pGPU6/GFP/Neo-shNC group, the difference is statistically signifi cant (p < 0.05); the difference between the blank group and pGPU6 /GFP/Neo-shNC group shows no statistical signifi cance (p > 0.05). This further proves that survivin gene expression can facilitate HSC apoptosis.
As an answer to the question whether the mechanism that inhibits survivin gene expression and promotes HSC apoptosis is related to caspase-3 expression, the research found that the caspase-3 protein expression was low in the blank group and pGPU6/ GFP/Neo-shNC group; the caspase-3 protein expression was high in pGPU6/GFP/Neo-siRNA group. The difference between the blank group and the pGPU6/GFP/Neo-shNC group showed no statistical signifi cance (p > 0.05); the difference between the blank group, pGPU6/GFP/Neo-shNC group and pGPU6/GFP/ Neo-siRNA group showed statistical signifi cance (p < 0.05). The survivin expression was inhibited and caspase-3 expression was promoted. Survivin expression is in negative correlation with caspase-3 expression. Wang JG's study on squamous cell carcinoma of tongue showed that the survivin expression was in negative correlation with caspase-3 expression (21) . Therefore, survivin possibly inhibits caspase-3 expression, thus resulting in obstructed cell proliferation and apoptosis (22) . Chu X found that the treatment of rectal cancer by inhibiting survivin gene expression with siRNA interference technology could enhance the expression of pro-apoptotic gene caspase-3 (23). Jeffrey C discovered that ET-1 modulates myofi broblasts susceptibility to apoptosis by increasing Survivin expression while inhibiting expression of survivin can trigger apoptosis in idiopathic pulmonary fi brosis (IPF) (24) .These facts are consistent with our study. Therefore, survivin could inhibit caspase-3 expression while impeding the HSC-T6 apoptosis, and thus cause HF; however, siRNA targeting survivin in the HSC-T6 can increase expression of caspase-3 and promote apoptosis, which may be proved an effective way to cure HF.
However, hepatic fi brosis could result from multiple factors and pathways. The question whether other factors or pathways can also cause hepatic fi brosis needs to be studied further.
Learning points
The siRNA targeting survivin in HSC-T6 can increase expression of caspase-3 and promote apoptosis, which may prove an effective way to cure hepatic fi brosis.
